Webinar

Make the move to PyroMAT™ System: the only cell line-based Monocyte Activation Test for the detection of pyrogens

Format: External webinar | Document type: Webinar

This content is provided by Merck KGaA, Darmstadt, Germany, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Make the move to PyroMAT™ System: the only cell line-based Monocyte Activation Test for the detection of pyrogens

For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug.

With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and Non Endotoxin Pyrogens), it’s now time to move away from animal-based test for pyrogen detection.

The new PyroMAT™ System provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!

Speakers

Laure Robert Laure Robert Global Product Manager for Pyrogen Test Solutions
Merck KGaA, Darmstadt, Germany

Anja Fritsch Anja Fritsch Chief Scientific Officer (CSO)
Confarma

Latest content from Merck KGaA, Darmstadt, Germany

New ready-to-use ISO CRM pharma impurity solutions for better testing

Paid for and content provided by Merck KGaA, Darmstadt, Germany

Improve the efficiency of your impurity testing

Improve the efficiency of your impurity testing with ready-to-use pharmaceutical impurity solutions manufactured as ISO approved Certified Reference Materials (CRMs)

Supplier info centre